Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Plan
SEC Form 4
Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 2,066 shares of common stock at $7 per share on May 15, 2024, under a pre-arranged trading plan.
Summary
- On May 15, 2024, Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc., sold 2,066 shares of the company's common stock.
- The sale was executed at a price of $7 per share.
- Following the transaction, Llewelyn directly owns 124,160 shares of Health Catalyst, Inc.
- The sale was conducted under a pre-arranged trading plan adopted on May 23, 2023, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Executive stock sales are a common occurrence, and sales under 10b5-1 plans are generally viewed as less impactful since they are pre-planned and not based on current insider information.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 05/23/2023 | Date the reporting person adopted the written trading plan in accordance with rule 10b5-1 |
| 05/15/2024 | Date of the stock sale transaction |
| 05/17/2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.